Data on Human papillomavirus (HPV) prevalence in renal transplant recipients in dynamics. Qualitative data on the presence of HPV was acquired using PCR and DNA isolated from cervical smears as a template. Expression of HPV oncogenes was determined by PCR using cDNA as a template (synthesized from RNA isolated from cervical smears). HPV load data were acquired using a commercially available PCR kit, and the data were processed per manufacturers' instructions (Sacace Biotechnologies). HPV types were determined using a commercially available semiquantitative PCR kit, and the data were processed per manufacturers' instructions (Seegene, South Korea). HPV L1-specific antibodies were detected using a specific commercially available ELISA test, and the data were processed per manufacturers' instructions (MyBioSource, USA). Clinical data were acquired from patient medical history.
|Date made available||24 Feb 2023|
|Publisher||Riga Stradins University|
|Date of data production||1 Sept 2013 - 31 Dec 2015|
Field of Science
- 3.1 Basic medicine
- cervical cancer